XML 16 R6.htm IDEA: XBRL DOCUMENT v3.22.4
Consolidated Statements of Cash Flows (Unaudited) - USD ($)
$ in Millions
 9 Months Ended
Dec. 31, 2022
Dec. 25, 2021
Cash flows from operating activities:    
Net income $ 490.4 $ 575.7
Adjustments to reconcile net income to net cash provided by operating activities:    
Depreciation and amortization expense 163.3 169.3
Deferred income tax expense (benefits) 21.3 (1.8)
Stock-based compensation expense 59.9 62.6
Impairment of assets 0.2 19.3
Bad debt expense (reversals) 0.2 (2.7)
Other non-cash charges (benefits) (1.3) 5.1
Changes in operating assets and liabilities:    
Accounts receivable (30.5) 31.7
Inventories (282.7) (211.6)
Prepaid expenses and other current assets (54.2) (37.8)
Accounts payable and accrued liabilities (24.3) 296.1
Income tax receivables and payables 69.9 (11.0)
Operating lease right-of-use assets and liabilities, net (9.8) (42.2)
Other balance sheet changes (5.4) (31.0)
Net cash provided by operating activities 397.0 821.7
Cash flows from investing activities:    
Capital expenditures (155.9) (113.6)
Purchases of investments (562.2) (1,234.8)
Proceeds from sales and maturities of investments 1,161.5 714.7
Other investing activities (5.2) (2.1)
Net cash provided by (used in) investing activities 438.2 (635.8)
Cash flows from financing activities:    
Repayments of long-term debt (500.0) 0.0
Payments of finance lease obligations (15.9) (16.8)
Payments of dividends (148.8) (101.1)
Repurchases of common stock, including shares surrendered for tax withholdings (445.8) (340.4)
Net cash used in financing activities (1,110.5) (458.3)
Effect of exchange rate changes on cash, cash equivalents, and restricted cash (23.2) (30.2)
Net decrease in cash, cash equivalents, and restricted cash (298.5) (302.6)
Cash, cash equivalents, and restricted cash at beginning of period 1,872.0 2,588.0
Cash, cash equivalents, and restricted cash at end of period $ 1,573.5 $ 2,285.4